UroGen Pharma

Home » UroGen Pharma

Secondary

UroGen Pharma

They are a clinical-stage biopharmaceutical company developing advanced non-surgical treatments to address unmet needs in the field of urology, with a focus on uro-oncology

Symbol

URGN

Last Closing Price
$42.46

Shares
1,130,000

Effective Date
January 19, 2018

Underwriters
Jefferies, Cowen & Co.

To view the prospectus for UroGen Pharma, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253